ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 620129 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 620129; 2) Community: the network communities that were significantly associated with the response to NSC 620129; 3) Molecule: the relationships between components within communities and NSC 620129; 4) MDR: the compounds that were significantly associated with the NSC 620129.

NSC Compound Enrichment Correlation
NSC 701022 Null 0.00503396694999381 0.074825422
NSC 719667 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one 0.00503396694999381 0.52295611
NSC 758670 TANNIC ACID 0.00503396694999381 -0.25123979
NSC 294846 Cinnoline, 4-nitro-, 1-oxide 0.00550789647802199 0.40883919
NSC 619102 4-Methoxy-1,5-benzothiazepine-1,1-dioxide 0.00550789647802199 0.69934958
NSC 645330 11H-Benzo[a]carbazole-1,4-dione, 7,11-dimethyl- 0.00550789647802199 0.77279345
NSC 653547 Null 0.00550789647802199 0.82795144
NSC 657561 (Z)-4-bromo-4-iodo-3-phenyl-3-buten-2-one 0.00550789647802199 0.60416406
NSC 661415 2-Chloro-3-(2-butoxyethoxy)naphthazarin 0.00550789647802199 0.73862515
NSC 679002 2-Butenedioic acid, 2-[3-[(ethoxycarbonyl)methyl]-2,4-dioxopyrimidin-1-yl]-, diethyl ester, cis- 0.00550789647802199 0.75967781
Total:74  Current:13    [First] [Prev] [Next] [Last]